Astrana Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,526	3,182	2,035	1,387	1,144	773.92
Revenue Growth (YoY)	56.69%	56.39%	46.72%	21.20%	47.84%	12.62%
Cost of Revenue	3,151	2,840	1,763	1,172	944.69	596.14
Gross Profit	375.95	341.53	271.39	214.96	199.48	177.77
Selling, General & Admin	235.1	217.26	154.11	112.6	77.67	62.08
Depreciation & Amortization Expenses	54.38	45.75	27.93	17.75	17.54	17.52
Total Operating Expenses	289.48	263.01	182.04	130.35	95.21	79.59
Operating Income	86.47	78.53	89.35	84.61	104.27	98.18
Interest Income	17.96	13.87	18.96	19.79	7.6	-2.74
Interest Expense	-41.2	-49.93	-33.1	-16.1	-7.92	-5.39
Other Non-Operating Income (Expense)	4	-2.86	5.61	1.54	-17.33	-12.3
Total Non-Operating Income (Expense)	-36.76	-38.92	-8.53	5.23	-17.65	-20.43
Pretax Income	49.71	39.61	80.82	89.84	86.62	77.75
Provision for Income Taxes	18.73	15.53	30.89	31.99	40.88	31.69
Net Income	30.23	22.49	43.15	60.72	45.17	68.92
Minority Interest in Earnings	0.76	1.59	6.78	-2.87	0.57	-22.87
Net Income to Common	30.23	22.49	43.15	60.72	45.17	68.92
Net Income Growth	-13.64%	-47.88%	-28.93%	34.42%	-34.46%	82.88%
Shares Outstanding (Basic)	49	49	48	47	45	44
Shares Outstanding (Diluted)	49	49	48	47	46	45
Shares Change (YoY)	2.41%	2.91%	2.20%	2.94%	0.44%	21.24%
EPS (Basic)	0.62	0.46	0.91	1.30	1.00	1.57
EPS (Diluted)	0.61	0.46	0.90	1.29	0.99	1.52
EPS Growth	-16.44%	-48.89%	-30.23%	30.30%	-34.87%	50.50%
Shares Outstanding	48.95	48.89	47.93	46.84	46.58	44.63
Free Cash Flow	154.99	104.49	44.17	39.7	59.19	51.11
Free Cash Flow Growth	48.33%	136.58%	11.26%	-32.93%	15.80%	13.58%
Free Cash Flow Per Share	3.14	2.12	0.92	0.85	1.30	1.13
Gross Margin	10.66%	10.73%	13.34%	15.50%	17.43%	22.97%
Operating Margin	2.45%	2.47%	4.39%	6.10%	9.11%	12.69%
Profit Margin	0.88%	0.76%	2.45%	4.17%	4.00%	5.95%
FCF Margin	4.40%	3.28%	2.17%	2.86%	5.17%	6.60%
EBITDA	140.85	124.27	117.28	102.36	121.81	115.7
EBITDA Margin	3.99%	3.91%	5.76%	7.38%	10.65%	14.95%
EBIT	86.47	78.53	89.35	84.61	104.27	98.18
EBIT Margin	2.45%	2.47%	4.39%	6.10%	9.11%	12.69%
Effective Tax Rate	37.67%	39.21%	38.22%	35.61%	47.19%	40.76%

SEC Filings: 10-K · 10-Q